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Abstract
Purpose Celiac disease (CD) is an autoimmune enterop-
athy, triggered by dietary gluten. The only treatment is a
strict gluten-free diet. Oats are included in the list of glu-
ten-free ingredients by European Regulation, but the safety
of oats in CD is still a matter of debate. The present study
examined the capability of different oat cultivars of acti-
vating the gliadin-induced transglutaminase-2 (TG2)-
dependent events in some in vitro models of CD. In addi-
tion, we compared this capability with the electrophoresis
pattern of peptic–tryptic digests of the proteins of the oat
cultivars.
Methods K562(S) cells agglutination, transepithelial
electrical resistance of T84-cell monolayers, intracellular
levels of TG2 and phosphorylated form of protein 42–44 in
T84 cells were the early gliadin-dependent events studied.
Results The results showed that the Nave oat cultivar
elicited these events, whereas Irina and Potenza varieties
did not. The ability of a cultivar to activate the above-
described events was associated with the electrophoretic
pattern of oat proteins and their reactivity to anti-gliadin
antibodies.
Conclusion We found significant differences among oat
cultivars in eliciting the TG2-mediated events of CD
inflammation. Therefore, the safety of an oat cultivar in CD
might be screened in vitro by means of biochemical and
biological assays, before starting a clinical trial to defi-
nitely assess its safety.
Keywords Celiac disease  Gluten-free diet  Oats 
Avenins
Introduction
Celiac disease (CD) is a permanent autoimmune enterop-
athy, triggered in genetically predisposed individuals by
dietary gluten [1, 2]. Gluten is a storage-protein fraction of
some cereals, such as wheat, rye and barley. Wheat gluten
encompasses two fractions: the alcohol-soluble gliadins
(monomeric) and the acid acetic-soluble glutenins (poly-
meric, whose subunits are linked to each others by disulfide
bonds). Gliadins are further classified in a- , b- , c- and
--gliadins according to their electrophoretic mobility,
glutenins in high and low molecular weight fraction. Both
gliadins and glutenins are toxic in CD. a-gliadin is the
main protein of wheat gluten [3].
In recent years, a growing body of evidence has shown
that the gliadin-dependent inflammation in celiac duodenal
mucosa is the result of a complex interaction of both innate
and adaptive immunity. In fact, the presentation of gliadin
epitopes by means of DQ2/8? antigen-presenting cells to
mucosal T cells is not sufficient to explain all the aspects of
the duodenal mucosa inflammation in CD [4]. It has been
recently described that the activation of the innate
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immunity by the ‘‘toxic’’ peptides, such as p31–43, sets the
tone of the mucosal response to gliadin, and it is required
for the downstream recognition of gliadin-specific
CD4? T cells [5]. The response to p31–43 in celiac
inflammation encompasses some very precocious trans-
glutaminase 2 (TG2)-dependent key events that occur at
the surface of intestinal epithelial cells, including increased
expression and activity of the enzyme TG2 itself, cyto-
skeleton rearrangement and protein phosphorylation [6, 7].
The prevalence of CD is estimated to be roughly 1 %
worldwide, and it is the most frequent food intolerance [8].
At present, the only treatment for this condition is the life-
long complete withdrawal of gluten from the diet [9, 10].
Strict adherence to a gluten-free diet (GFD) is required to
control the symptoms of CD and to prevent the autoim-
mune and neoplastic complications associated with this
condition [11]. However, full compliance with GFD
heavily affects dietary choice and the quality of life.
Although the quality of gluten-free foods has significantly
improved in the last decades, some problems still remain
partially unresolved, in particular the lower technological
performances of gluten-free cereals [12].
On these bases, the inclusion of oats in GFD could be of
great value. Oats are a good source of fiber and in partic-
ular b-glucans, which are healthy compounds that reduce
serum LDL cholesterol and the glycemic index of food-
stuffs [13, 14]. Moreover, the inclusion of oats in GFD can
offer a wider choice for celiac patients. Although oats are
included among the gluten-free ingredients by European
Commission Regulation 41/2009 [15], the safety of oats in
CD is still a matter of debate. Some clinical trials have
concluded that oats are well tolerated by CD patients on
GFD [16–19], but earlier studies found that some patients
consuming oats as part of GFD suffered an intestinal
inflammation similar to that in untreated celiac patients
[20–22].
These contradictory results might be explained by the
fact that the variety of oats used in the challenges was not
taken into account. Oats include many varieties, naked and
husked seeds, containing various amino acid sequences
[23] and showing different immunoreactivities to anti-gli-
adin polyclonal antibodies [24]. We have previously
reported that the prolamin avenins (the proteins corre-
sponding to wheat gliadin) from different oat cultivars
display different immunostimulatory activities on celiac
lymphocytes from peripheral blood [25]. Comino et al. [26]
have confirmed that the immunogenicity of oats on celiac T
lymphocytes differs for different cultivars and showed a
direct correlation between the immunogenic ability of the
oat cultivars and the concentration of the immunostimu-
latory gliadin peptide 33mer in their protein fraction.
However, the activation of T cells by immunogenic
p33mer is a very late event in the inflammatory cascade of
CD; a grain to be considered safe in CD should also not
trigger the very early TG2-dependent events of epithelial
activation [5].
We have therefore studied different oat cultivars in
in vitro and ex vivo models of celiac epithelial activation
and compared the capacity to activate this pathway with
the oat protein profile.
Materials and methods
Cereal samples
Three naked cultivars of Avena sativa L. (cv. Irina, cv.
Potenza e cv. Nave) were included in the study. Oat cul-
tivars Irina and Potenza were provided by Heinz Italia
S.p.A. (Latina, Italy). Seeds were finely ground by a coffee
mill exclusively used for gluten-free ingredients. Rice
(Oryza sativa L.) and wheat (Triticum aestivum L.) flours
were used as negative and positive controls, respectively.
Gluten contamination in the samples of oats and rice was
assessed by RIDASCREEN Gliadin ELISA kit (R-Biop-
harm AG, Darmstadt, Germany).
Peptic–tryptic digestion of cereal proteins
The proteolysis of oats, wheat and rice flours was per-
formed by sequential digestion with purified pepsin and
trypsin. Five grams of each cereal flour was suspended in
50 mL of 0.1 N HCl containing 10 mg of pepsin from
porcine gastric mucosa (EC 3.4.23.1, Merck, Damstadt,
Germany) and was incubated at pH 2.0 and 37 C for
3 min, 10 min or 2 h. Then, the pH of the samples was
adjusted to 8.0, with 0.2 N NaOH and 10 mg of trypsin
from bovine pancreas (EC 3.4.21.4, Sigma, Milan, Italy)
was added and allowed to act for 2 or 4 h. The digestion
was stopped by adjusting at pH 7 with 0.1 N HCl. All
digestions were performed at least in duplicate. Incubations
without enzymes under the same conditions were per-
formed to obtain undigested samples (Time 0).
For SDS-polyacrylamide gel electrophoresis (PAGE)
analysis, 1 mL of each digestion solution was diluted (1:1;
v/v) with sample buffer containing 0.125 M Tris–HCl pH
6.8, 3.75 % glycerol, 1 % SDS and 5 % b-mercap-
toethanol. For the in vitro studies on cells, an aliquot
(5 mL) of each digestion solution was freeze dried (freeze-
dryer Edwards Modulyo, UK).
Oats and rice digests were tested to be gluten contami-
nation-free with the ELISA kit-containing antibodies ver-
sus R5-peptide (R-Biopharm, Darmstadt, Germany). All
the digests were tested endotoxin-free using the Pyrotell
Limulus amebocyte Lysate assay (Cape Cod Inc., Fal-
mouth MA, USA).
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SDS-PAGE
The electrophoresis profile of oats, rice and wheat flours as
well as that of their corresponding digestion products was
analyzed by SDS-PAGE under reducing conditions in a gel
having the following composition:
Gradient running gel 9–19 % acrylamide, 0.08–0.17 %
bis-acrylamide, 0.36 M Tris–HCl buffer pH 8.8, 35 %
glycerol, 0.1 % SDS, 0.02 % ammonium persulfate and
0.15 % N,N,N0,N0-tetramethylenediamine (TEMED).
Stacking gel 3.5 % acrylamide, 0.09 % bis-acrylamide,
0.125 M Tris–HCl buffer pH 6.8, 0.1 % SDS, 0.02 %
ammonium persulfate and 0.15 % TEMED.
Running buffer 25 mM Tris–HCl pH 8.8, 0.19 M glycine
and 0.1 % SDS (w/v).
Prestained molecular weight marker solution (broad
range, Bio-Rad) contained myosin (192.8 kDa), b-galac-
tosidase (117.9 kDa), bovine serum albumin (99.3 kDa),
ovalbumin (54.1 kDa), carbonic anhydrase (37.8 kDa),
soybean trypsin inhibitor (29.5 kDa), lysozyme
(20.2 kDa) and aprotinin (7.4 kDa). After the electro-
phoretic run (90 V at room temperature for approxi-
mately 6 h), gels were dyed with Coomassie Brilliant
Blue G-250. All materials and instruments were pur-
chased from Bio-Rad (Hercules, CA, USA).
Immunoblotting
The immunoreactivity in samples was tested using
immunoblotting and a commercial antibody specifically
developed against wheat gliadins. After SDS-PAGE,
proteins were transferred to a PVDF membrane (Milli-
pore, Billerica, MA) by Western blotting in a Trans-blot
Electrophoretic Transfer Cell (Bio-Rad). The membranes
were blocked with 1 % gelatin and washed three times
with 0.25 % gelatin solution (150 mM NaCl, 5 mM Tris
and 0.05 % Triton X) to prevent nonspecific adsorption
of the immunological reagents. The membrane was then
immersed in 10 mL of 0.25 % gelatin solution contain-
ing 10 lL of a rabbit anti-wheat gliadin polyclonal
antibody (Sigma Aldrich, Italy), and antigen–IgG com-
plexes were detected using 10 lL of mouse anti-rabbit
IgG monoclonal antibodies labeled with alkaline phos-
phatase (Sigma Aldrich Italia). After incubation in the
bromochloroindolyl phosphate-nitroblue tetrazolium
(BCIP/NBT) solution, a black-purple precipitate devel-
oped at the site of the enzyme binding. The developing
solution contained 15 % bromochloroindolyl phosphate
and 30 % nitroblue tetrazolium in alkaline phosphatase
buffer (100 mM Tris, 100 mM sodium chloride and
5 mM magnesium chloride, pH 9.5).
Cell lines
Human leukemic K562(S) and human colon adenocarci-
noma T84 cell lines were obtained from American Type
Culture Collection (commercialized in Italy by LGC
Standard, Milan) and cultured as previously described [27].
K562(S) cell agglutination test
The K562(S) cell agglutination test was performed as
previously described [27]. Briefly, K562(S) cells were
harvested by centrifugation and washed twice with Ca2?
and Mg2?-free PBS (GIBCO, Carlsbad, CA, USA) and
resuspended at a concentration of 108 cells/mL in the same
PBS. Twenty-five lL of cell suspension was added to each
well of a 96-well microtiter plate containing the PT digest
of the cereals (7 mg/mL). The final total volume was
100 lL. The cell suspension was incubated at room tem-
perature (RT) for 30 min. The agglutinating activity of the
different digests was measured using a 96 plate reader
equipped with a stirrer (Bio-Rad, Hercules, CA, USA). The
cell suspension turbidity was read at 600 nm (OD 600 nm)
under continuous stirring at time 0 and after 30 min. The
difference in readings between that at T0 and T30 9 100
was calculated as a velocity of agglutination (CV).
Measurement of transepithelial electrical resistance
across T84 cell monolayer
T84 cells were seeded on polycarbonate inserts (0.45 mm
pore diameter, 0.9 cm2 area; (BD Falcon, Franklin Lakes,
NJ, USA) and left to grow to full confluence for at least
19 days, in order to establish a cell monolayer. The for-
mation of the cell monolayer was ensured by measuring a
transepithelial electrical resistance (TEER) value of at least
800 X ms/mm2, using a Millicell ERS device (Millipore,
Bedford, MA, USA). The digestion products from different
cereals studied in this paper were added (1 mg/mL at
37 C) to the culture medium of T84 cells for 3 h. The
impact of the different digests on monolayer permeability
was expressed as the difference in the TEER value mea-
sured after 3-h incubation with the digest, and the TEER
value measured just before the addition of the digest to the
cell culture (DX ms/mm2).
Western blotting of p42–44 and TG2 protein
in T84 cells
T84 cells were seeded in 6-well plates and challenged after
5 days, at the pre-confluence stage, with the PT digests of
cereals (1 mg/mL) for 3 h for the determination of p42–44
expression and 24 h for the determination of TG2 expres-
sion. Independently, whole cell extracts were washed twice
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in ice-cold PBS, resuspended in 150 mM NaCl, 1 % Triton
X-100 1 % (Sigma, St Louis, MO, USA) and a mixture of
protease inhibitors (1:50) (Sigma) and incubated on ice for
20 min and then centrifuged for 5 min at 4 C. The
supernatant was stored at -70 C as whole cell protein
lysate. SDS–PAGE was carried out on 4 % stacking and
7.5 % resolving gel (Bio-Rad, Hercules, CA, USA). Equal
amounts of protein (50 mg) were loaded in each lane with
loading buffer containing 0.1 Tris (pH 6.8), 20 % glycerol,
10 % mercaptoethanol, 4 % SDS and 0.2 % Bromophenol
Blue (Bio-Rad). Samples were heated at 100 C for 5 min
before gel loading. After electrophoresis, the proteins were
transferred to a PVDF membrane (Bio-Rad). Membranes
were blocked for 1 h with 5 % nonfat milk in TBS
(100 mM NaCl, 5 mM KCl, 100 mM Tris–HCl, pH 7.4
and 0.05 % Tween 20, Bio-Rad) and incubated overnight
with phosphorylated form of p42–44 (mouse Ab, used at
dilution 1:1,000, Cell Signaling, Danvers, MA, USA) or
TG2 antibody (mouse Ab, used at dilution 1:100, clone
CUB 7402, Abcam, Cambridge, MA, USA) and then
washed three times for 5 min in TBST. Secondary antibody
(goat-antimouse, conjugated to horse-radish peroxidase
HRP) (Bio-Rad) was diluted 1:3,000 in the blocking
solution, added to membranes for 1 h at RT and then
washed three times in TBS for 5 min. Proteins on mem-
branes were revealed by the chemiluminescence detection
kit (Bio-Rad), according to manufacturer’s instructions.
Intensities of protein bands on blots were measured using
the Bio-Rad ChemiDoc densitometer. Membranes were
stripped and reprobed with b-actin antibody (Abcam)
diluted 1:400 to verify equal loading of proteins. The
density of the blots was analyzed with a densitometric
software (Bio-Rad), which quantifies the intensity of the
bands. The figures so obtained were normalized for the
corresponding actin intensity and expressed in a graph.
Patients
Duodenal biopsies were performed for diagnostic purposes
in three untreated celiac patients. The histological and
serological profiles of these patients are described in
Table 1. Written informed consent was obtained from
parents of the children involved, and the study was
approved by the Ethics Committee of Istituto Superiore di
Sanita`. One specimen from each patient was used for
diagnosis; the other samples were cultured in vitro as
follows.
In vitro organ culture of biopsy specimens
from celiac patients
Duodenal specimens were put on a metallic grid in a Petri’s
dish and partially immersed in RPMI supplemented with
FCS (10 %), penicillin/streptomycin, HEPES and nones-
sential amino acids and glutamine. The specimens were
exposed to the PT digest (1 mg/mL) of different cereals for
3 h and then embedded in optimal cutting temperature
(Bioptica, Milano, Italy). Tissue sections of 5 lm obtained
in the cryostat were fixed in acetone to methanol 1:1 for
20 min at 4 C and incubated with a 1 % BSA for 20 min
to prevent nonspecific antibody binding. The sections were
then incubated with TG2 antibody (CUB7402 Abcam;
1:1000) for 1 h at RT and then with AlexaFluor 660 sec-
ondary antibody (1:500, Life Technologies) for 60 min at
RT. The images were acquired with a fluorescence
microscope.
Statistical analysis
Cells treated with PT digests of oats or wheat flour were
compared with cells treated with PT digests of rice flour.
All experiments were performed in triplicate. Data distri-
bution was analyzed and statistical differences were eval-
uated using Wilcoxon test and SPSS 12 software. A
P value of \0.05 was considered significant.
Results
Oats protein profiles
The protein profiles of oats, rice and wheat samples at
some of the different times and types of digestion per-
formed in this study (nondigested, pepsin for 3 min, pepsin
for 2 h and then trypsin for 2 h, pepsin for 2 h and then
trypsin for 4 h) obtained with SDS-PAGE are illustrated in
Fig. 1. The patterns of undigested Irina, Potenza and Nave
oat cultivars showed a mixture of proteins including oat
prolamins (outlined boxes in the figure). Pepsin digestion
for 3 min brought about significant proteolysis in both Irina
and Potenza oats: the number and intensity of protein bands
decreased progressively during pepsin digestion for 10 min
and 2 h (results not shown) and almost disappeared after
the combined action of pepsin (2 h) and trypsin (both 2 and















1 7.5 M 87 ??? 3c
2 10.8 F 58 ?? 3b
3 8.1 F 71 ??? 3c
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4 h). Oats cv. Nave presented a different protein distribu-
tion and a general lower abundance. Pepsin digestion for
3 min of Nave oats caused little proteolysis and even after
the combined action of pepsin (2 h) plus trypsin (2 h), a
significant amount of avenins was still present; it took
trypsin digestion for 4 h to remove them completely. Rice
flour presented three main protein bands with molecular
weights ranging from 6 to 30 kDa. Digestion of rice with
pepsin for 3 and 10 min (data not shown) had little effect in
its protein pattern, but digestion with trypsin for 2 h vir-
tually removed all the bands; whereas, the lowest molec-
ular weight proteins of wheat digests resisted to trypsin
attack.
Figure 2 shows the results of immunoblotting obtained
after incubation of the cereals samples, illustrated in Fig. 1,
with polyclonal anti-gliadin antibodies. Undigested oats cv.
Irina and Potenza showed a very low reactivity, which
completely disappeared at digestion time as short as 3 min
with pepsin. The Nave cultivar presented high immunore-
activity at time 0 decreasing after 2 h of pepsin and trypsin
and a weak increase after 4 h of trypsin, which could be due
to the production of reactive fragments after prolonged
attack. Like the oats, undigested rice showed a weak
immunoreactivity to the anti-gliadin antibody (Fig. 2, right),
but in contrast, this binding survived peptic and tryptic
digestions. As expected, wheat samples showed strong
immunochemical reactivity throughout all digestion periods.
Agglutination of K562(S) cells
We have previously shown [27] that the agglutination of
myelogenic leukemia cells K562(S) by toxic gliadin




















Fig. 1 SDS-PAGE pattern of three different oat cultivars, rice and
wheat flours digested for different times of digestion with pepsin or
pepsin/trypsin. The outlined boxes include the bands encompassing
the avenins fractions. I = oats var. Irina; P = oats var. Potenza;
N = oats var. Nave; R = rice; W = bread wheat; MK = molecular
weight standard solution; 0 = undigested samples; 3 = digested with
pepsin for 3 min; 2 ? 2 = digested for 2 h with pepsin ? 2 h with
trypsin; and 2 ? 4 = digested for 2 h with pepsin ? 4 h with trypsin



















Fig. 2 Immunoblotting of the different digestion products illustrated
in Fig. 1, obtained after incubation with rabbit anti-gliadin polyclonal
antibodies. I = oats var. Irina; P = oats var. Potenza; N = oats var.
Nave; R = rice; W = bread wheat; MK = molecular weight
standard solution; 0 = undigested samples; 3 = digested with pepsin
for 3 min; 2 ? 2 = digested for 2 h with pepsin ? 2 h with trypsin;
and 2 ? 4 = digested for 2 h with pepsin ? 4 h with trypsin
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peptides relies upon the activity of cellular TG2, an
enzyme involved in the very precocious events triggered
by these peptides at the cell surface of duodenal epi-
thelial cells. Briefly, the Ca2?-dependent TG2 activation
triggered by p31–43 in K562 cells leads to cytoskeleton
rearrangement, which is a key event in cell agglutination.
This cell line therefore offers a useful and rapid tool for
evaluating the ability of a cereal to trigger the epithelial
activation in CD. We incubated oat cultivar digests with
K562(S) cells for as little as 30 min before reading the
agglutination time (Fig. 3). The negative control (rice
flour) did not induce cell agglutination for any time of
PT digestion, whereas wheat flour, used as positive
control, triggered a massive agglutination of the
K562(S) cells regardless of the time of PT digestion. The
exposure of K562(S) cells to the PT digests of both oat
cultivars Irina and Potenza did not result in cell agglu-
tination, whereas some of the PT digests from oat cul-
tivar Nave did agglutinate the K562(S) cells, though with
a lower agglutination velocity than wheat flour. This
result confirms the toxicity previously described for Nave
oats in some in vitro models of CD inflammation [25].
Permeability of T84 cell monolayer
Gliadin-dependent early events, similar to those responsi-
ble for K562(S) cells agglutination, also occur at the sur-
face of the gliadin-sensitive cell line T84 [6]. The
cytoskeleton rearrangement induced by p31–43 in these
cells causes an increased permeability of the cell mono-
layer, when T84 cells are grown on a polycarbonate filter in
a bidimensional cell culture system [27]. We screened the
effect on the TEER of a T84 cell monolayer after a 3 h
incubation with the PT digests.
As shown in Fig. 4, the incubation of the bidimensional
cell culture system with all the wheat PT digests resulted in
a significant decrease in the TEER compared with oats PT
digests. Regarding the oats, only the Nave oats digested
with pepsin and trypsin for the longest time affected the
TEER; no effect was noticed for PT digests of Irina and
Potenza oats.
At this point of the experimental procedure, it was clear
to us that wheat flour was capable to trigger the celiac
epithelial activation regardless the type and the time of































Fig. 3 Measurement of the agglutination velocity of K562(S) cells
incubated with the flour PT digest of the mentioned cereals,
progressively digested. K562(S) agglutination is a TG2-dependent
mechanism induced only by cereal toxic in CD. The agglutination
velocity is expressed as the difference in reading at 600 nm with a
plate reader of cell suspension turbidity at time 0 and time 30 min
after the incubation with the digests. Higher the difference is, higher
the agglutination velocity is. Bread wheat only resulted to induce a
fast K562(S) cell agglutination, regardless the time of digestion,
whereas the incubation of the cells with flour rice digests do not result
in cell agglutination. Results are expressed as mean ± SD of three
different experiments, each performed in triplicate. *P \ 0.05.
Statistical analysis performed by Wilcoxon test versus cells incubated
with the corresponding rice PT digest (negative control)
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found not toxic. Concerning the oats, all the PT digests of
Irina and Potenza cultivars were shown to be not toxic,
whereas only Nave digested with pepsin for 2 h and trypsin
for 4 h elicited the cell surface events. So, we decided to
use only this type of digestion, which fully mimics the
human gastro-intestinal digestion, for the following more
complex and time-demanding experiments of this study.
The toxicity observed in this in vitro test is fully in
agreement with proteolysis pattern as observed in SDS-
PAGE and immunoreactivity illustrated in Fig. 2.
TG2 and p42–44 expression in T84 cells
P31–43 accumulates into the lysosome, impacting on the
TG2-degradation machinery. The increased intracellular
levels of TG2 led to a PPAR-c downregulation, which is a
key event in the derangement of the intracellular environ-
ment of celiac intestinal epithelial cells [7]. The phos-
phorylation of cellular protein 42–44 has been
demonstrated to be a good index of early cereal toxicity in
CD [6, 28].
Therefore, we analyzed the expression of both TG2 and
phosphorylated p42–44 in T84 cells treated with the PT
digests of oats flours. As expected, the incubation of cells
with wheat dramatically over-expressed TG2 and p42–44
compared with cells treated with rice-flour digest. The
incubation of T84 cells with Irina or Potenza oats did not
exert any effect on the cellular expression of these two
molecules, whereas the digest of Nave oats increased the
levels of TG2 and p42–44 in a similar way to wheat
(Fig. 5).
To confirm the results obtained with Western blotting,
we performed the TG2-immunofluorescence staining on
sections of celiac duodenal specimens exposed in vitro to
oats PT digests. TG2 expression increased in celiac mucosa
when exposed overnight to PT digests of wheat and Nave
oats compared with samples exposed to rice digest; on the




















Fig. 4 Variation in the TEER in T84 cells grown on a filter of
polycarbonate. Results are expressed as the difference in the TEER
value (DX ms/mm2) measured after 3-h of incubation with the digests
and the TEER value measured just before the addition of the digests
to the cell culture. The positive variation in the TEER is a cell
surface-associated event induced by cereal toxic in celiac disease.
Bread wheat only resulted to induce a significant variation in the
TEER. Results are expressed as mean ± SD of three different
experiments, each performed in triplicate. *P \ 0.05. Statistical
analysis performed by Wilcoxon test versus cells incubated with the
corresponding rice PT digest (negative control)
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with Irina and Potenza oats resulted comparable with that
of specimens incubated with rice flour (Fig. 6).
Discussion
In this study, we have shown that there is a significant
difference among oat cultivars in eliciting the very preco-
cious events occurring at the cell surface and triggering the
downstream mucosa inflammation in CD. Furthermore, we
found an association between the toxicity of oat cultivar
digests and the electrophoresis pattern and the reactivity to
anti-gliadin polyclonal antibodies.
Fragments derived from the gastro-intestinal digestion
of gliadin activate specifically the innate or the adaptive
immune system in celiac mucosa. The former are termed
‘‘toxic’’ peptides, the latter ‘‘immunodominant’’ peptides.
Among the toxic sequences, p31–43 is the best known
[5, 29], but several other peptides are able to act as
inductors of this stage of the immunity in celiac mucosa
[30]. Six gliadin epitopes have been found so far and all
of them are included within the sequence of a 33-amino
acid long peptide, which is resistant to the proteolysis by
human gastro-intestinal enzymes [31]. The exposure of
duodenal mucosa to p31–43 is required not only to
predispose the T lymphocytes to the late adaptive
immune response, but also to induce some very early
inflammatory events, occurring at the surface of epithe-
lial cells [32]. On the contrary, the exposure of the celiac
duodenal mucosa to any of gliadin immunomodulatory
epitopes alone does not exert any effect. Recent studies
have shown that both phases of immune response to


























rice   wheat Irina Potenza Nave
actin 42 kD
Fig. 5 a Expression of gliadin-dependent epithelial pro-inflammatory
molecules p42–44 and TG2 in T84 cells exposed in vitro for three and
24 h, respectively, to PT digests of the cereals indicated, as resulted to
Western blotting analysis. The density of the blots was quantified with
a densometric software and was normalized for actin expression.
Results are expressed as mean ± SD of three different experiments,
each performed in triplicate. *P \ 0.05. Statistical analysis performed
by Wilcoxon test versus PT rice-treated group. b The figure represents
the result of an experiment out of the three WB performed
PT rice PT oats Potenza PT oats NavePT oatsI rina
PT bread wheat
Fig. 6 Expression of TG2 in celiac duodenal mucosa specimens
challenged in vitro with the peptic–tryptic digest (PT) of the indicated
flour (1 mg/mL) for 24 h. The increase expression of TG2 in celiac
small bowel mucosa is a very precocious event of gliadin toxicity in
celiac inflammation. The incubation of mucosa specimens with flour
PT digests of Potenza and Irina oat cultivars failed to induce TG2
expression in the mucosa specimens, as the digest of rice flour. On the
contrary, PT digest of oat cultivar Nave induced a marked TG2
expression in celiac mucosa specimens, in a similar manner of PT
digest of the bread wheat. Magnification 940
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enzyme plays a role so essential in CD pathogenesis that
its down-regulation is currently under study as an alter-
native therapy to GFD [10]. All the events investigated
in this in vitro study are TG2 dependent. Particularly,
Irina and Potenza oats, differently from Nave oats, do
not impact the TG2-mediated cytoskeleton rearrangement
in K562(S) and T84 cell lines and the TG2 expression in
T84 cells and celiac mucosa. Although it is always
difficult to compare different studies, we confirm the
results obtained by Maglio et al. [33] that showed that
Potenza oats completely fail to activate the innate
immune response in human intestinal epithelial cell line
Caco-2 and celiac duodenal mucosa. These authors,
however, reported that Potenza oats in vitro increased the
number of T lymphocytes in specimens of celiac duo-
denal mucosa. As discussed above, this event occurs late
in the downstream inflammatory cascade pathogenetic in
CD and requires the trigger of the mucosal innate
immunity. Therefore, it does not necessarily indicate that
this oats is toxic in CD.
Our data give further support to the conclusions by
Comino et al. [26], who described that some oat cultivars
have no immunogenic activity on celiac peripheral lym-
phocytes. Although we tested different oat varieties, the
present paper completes and integrates these findings,
describing the oats impact on the very early TG2-depen-
dent inflammatory CD events, whereas the paper by Co-
mino et al. investigated downstream events in the
inflammatory cascade of CD.
The toxicity observed in in vitro tests was fully in
agreement with proteolysis pattern as observed in SDS-
PAGE and immunoreactivity versus polyclonal anti-gliadin
antibodies. We have used polyclonal antibodies to identify
the potential toxic fragments within avenins sequences rather
than searching the presence of p31–43, since this sequence is
only one among several gliadin toxic peptides, whose exact
number and sequences are still unknown. Moreover, poten-
tial oats toxic peptides could have significant differences in
amino acid sequences. Oats is a cereal that includes numer-
ous cultivars; they widely differ between protein content and
avenins composition, which can be responsible for the dif-
ferent affinities observed between prolamins and anti-gliadin
antibodies [34]. The weak immunoreactivity to anti-gliadin
antibodies showed by rice digests might be due to a non-
specific binding of the polyclonal antibodies (reacting not
only to toxic sequences) to rice proteins, whereas the R5
antibody is a monoclonal antibody that recognizes very
specifically the gluten toxic sequence QQPFP [35].
To conclude, the inclusion of oats in a GFD might be
valuable for the nutritional and health benefits of this cer-
eal. Although the definitive proof whether a specific oat
cultivar is suitable for CD patients may come from ran-
domized double-blind placebo-controlled clinical trial, it
might be a useful preliminary in vitro screening of the
cultivar toxicity or safety by means of biochemical and
biologocial assays.
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